Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-16

Clinical Trial Update: Usefulness of Selegiline as an Aid to Quit Smoking - 1 [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating selegiline as an aid to quitting smoking have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Selegiline (selegiline)

Snippet

Sponsor: Yale University | Conditions: Tobacco Use Cessation | Phase 2 | Status: COMPLETED | Results posted: 2014-07-16